PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Acarizax (house dust mite) - Allergen immunotherapy
PAD Profile : Acarizax (house dust mite) - Allergen immunotherapy
Keywords :
House dust mite allergens
Brand Names Include :
Acarizax
Traffic Light Status
Status 1 of 1.
Status :
Red
Important
Formulations :
- Oral lyophilisates
Important Information :
RSFT Immunology and specialist paediatricians only. Approved in over 18s only. Licensed in children over 12 years.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
- House dust mites allergen extract
- Pollen allergy preparations
- Wasp and bee venom allergy preparations
- House dust mites allergen extract
- Pollen allergy preparations
- Pollen allergy preparations
- White Birch pollen allergen extract
- Wasp and bee venom allergy preparations
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
06 November 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Associated BNF Codes
03. Respiratory System
03.04.02. Allergen immunotherapy